You just read:

Jazz Pharmaceuticals Completes Rolling Submission of New Drug Application for Vyxeos™ (CPX-351), an Investigational Treatment for Acute Myeloid Leukemia

News provided by

Jazz Pharmaceuticals plc

Apr 03, 2017, 09:05 ET